Cancer Therapies for APPs: A Comprehensive Review (On-Demand) 2026

Overview

Over the past several decades, cancer therapy has evolved from conventional chemotherapy to targeted agents, immunotherapy, and other novel approaches. To help APPs and other clinicians navigate how these therapies are used to treat solid tumors and hematologic malignancies, Horizon CME has developed “2026 Cancer Therapies for APPs: A Comprehensive Review”. In this virtual two-day program, clinicians will gain understanding of the various classes of cancer therapy, their mechanisms of action, safety profiles, and applicability in hematologic malignancies and solid tumors. Participation in this program will provide APPs with the practical knowledge they need to provide support and care for patients with cancer.


Learning Objectives

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By
Horizon CME Logo

 

Course summary

Available credit: 
  • 12.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 12.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12.00 ANCC

    This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 12.00 credit.

  • 11.75 Pharmacology

    This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 11.75 credit.

Course opens: 
09/23/2026
Course expires: 
09/23/2027
Cost:
$225.00
Rating: 
0

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, prior to an activity, Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.

Planners
N/A

*Horizon CME has mitigated and resolved all relevant financial relationships

Faculty

Elizabeth Krueger, NP discloses the following relevant financial relationship(s), Advisory Board role with Johnson and Johnson, and Speaker role with Curio Science both relationships have ended during the past 24 months.

Courtney Cavalieri, PharmD, BCOP discloses the following relevant financial relationship(s): active Advisory Board roles with Nuvalent and Daiichi Sankyo, Inc, and an Advisory Board role with Bristol Myers Squibb (ended) during the past 24 months.

Heather N. Moore, PharmD, BCOP, CPP discloses the following relevant financial relationship(s): an active Consultant role with AstraZeneca, and Consultant roles with Novartis, Genentech, Gilead, and Lilly that have ended within the past 24 months.

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Available Credit

  • 12.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 12.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12.00 ANCC

    This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 12.00 credit.

  • 11.75 Pharmacology

    This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 11.75 credit.

Price

Cost:
$225.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above